Search
The discovery suggests a potential new treatment approach for certain cancers.
Every year, the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) awards fellowships to students who show promise in their scientific endeavors at GSK.
New research from scientists at the Sloan Kettering Institute helps explain how growing tumors escape our immune defenses.
Four students have been awarded 2012 Ruth L. Kirschstein National Research Service Awards from the National Cancer Institute.
Learn about novel therapies emerging for the treatment of mantle cell lymphoma.
COVID-19 is continuing to make headlines around the world this year. Yet cancer will kill a larger number of people globally – 10 million every year. Patients with cancer are more vulnerable to contracting COVID-19, and have more than double the death rate from COVID-19 compared to patients without cancer.
Neuropathologist and scientist Jason T. Huse has been selected by the Sontag Foundation as one of three Distinguished Scientist Award recipients for 2012.
Neuro-oncologist and renowned physician-scientist Ingo Mellinghoff will lead MSK’s distinguished Department of Neurology after previously serving as Acting Co-Chair.
Memorial Sloan Kettering Cancer Center chemist Samuel J. Danishefsky will be honored with three major awards this spring. Dr. Danishefsky is the incumbent of a Eugene W. Kettering Chair and a member of the Molecular Pharmacology and Chemistry Program in the Sloan Kettering Institute.
President Biden announced on September 15 his appointment of MSK medical oncologist and Head of the Division of Solid Tumor Oncology, Luis Alberto Diaz, Jr., MD, as one of seven distinguished members of the National Cancer Advisory Board.